SCHEMBL10275533

SCHEMBL10275533

N#Cc1ccc(-c2c(-c3ccc(C(F)(F)F)cc3)nc3[nH]c(N)cc(=O)n23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.43
DGAT1 O75907 1/20 0.41
SOAT1 P35610 1/20 0.41
KCNH2 Q12809 1/20 0.41
XDH P47989 1/20 0.40
KDM1A O60341 6/20 0.39
KDM5A P29375 1/20 0.38
KIT P10721 2/20 0.37
MAOB P27338 2/20 0.36
PSD A5PKW4 1/20 0.36
MYC P01106 1/20 0.35
WDR5 P61964 1/20 0.35
CYP3A4 P08684 1/20 0.34
CYP3A5 P20815 1/20 0.34
TRPA1 O75762 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN9A Q15858 1/20 0.34
NSD2 O96028 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10276273 0.88 KIF11 (0.44) KIF11DGAT1SOAT1KCNH2XDH
SCHEMBL10275786 0.88 KIF11 (0.44) KIF11DGAT1SOAT1KCNH2XDH
SCHEMBL10275820 0.83 MEN1 (0.43) KDM1AKIT
SCHEMBL10276272 0.82 KIF11 (0.38) KIF11DGAT1SOAT1KCNH2KDM1A
SCHEMBL10275891 0.82 KDM4E (0.45) KIF11DGAT1SOAT1KCNH2KDM1A
SCHEMBL10276237 0.81 KDM1A (0.37) KIF11DGAT1SOAT1KCNH2KDM1A
SCHEMBL10275347 0.80 ADORA1 (0.40) KCNH2KDM1ANSD2GABRG2GABRB3
SCHEMBL10276567 0.77 GCGR (0.38) KIF11DGAT1SOAT1KCNH2KDM1A
SCHEMBL10275689 0.77 GCGR (0.38) KIF11DGAT1SOAT1KCNH2KDM1A
SCHEMBL10275808 0.77 MEN1 (0.41) KDM1AKDM5AKITTRPA1SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US claimed
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US disclosed
WO-2011035518-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF 辽宁利锋科技开发有限公司 (CN) 2011-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 KIF11 4069/4885DGAT1 4032/4885SOAT1 3883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.